Pay in 4 interest-free payments of $6.49 Learn more
Ships within 48 hours · Estimated delivery Oct 30 - Nov 4
Clinical trial status Eli Lilly is running seven Phase 3 clinical trials evaluating retatrutide for obesity, type 2 diabetes, and related metabolic conditions
d g , Selected enriched annotations
Outcomes IIH is a neurological condition characterized by increased ICP without a known etiology
What are the ongoing costs
Understanding Semaglutide, Tirzepatide, and Retatrutide Semaglutide, Tirzepatide, and Retatrutide are injectable medications that aid in weight loss by targeting key metabolic pathways
Cagrilintide is an investigational novel long-acting acylated amylin analogue, acts as nonselective amylin receptors (AMYR) and calcitonin G protein-coupled receptor (CTR) agonist
US$ 22.74
US$ 26.76
US$ 26.78
US$ 27.69
US$ 20.32
US$ 21.56
